News
PACB
3.750
+0.81%
0.030
Weekly Report: what happened at PACB last week (0318-0322)?
Weekly Report · 3d ago
Canaccord Genuity Maintains Buy on Pacific Biosciences, Lowers Price Target to $10
Benzinga · 6d ago
Pacific Biosciences' Pivot: From Shareholder Dilution To Expansion And Leadership
Pacific Biosciences is expanding with Revio and Onso sequencing technologies. The company's annual revenue is expected to grow 25% through 2029. PacBio is a company developing and producing advanced sequencing solutions. Despite 10% growth since 2015, dilution has eroded shareholder value. Despite this, analysts see a 178% upside potential for the company. It's a gradual Speculative Buy with an expected return of +29%.
Seeking Alpha · 03/19 16:42
Top 5 Health Care Stocks Which Could Rescue Your Portfolio In March
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its weakness. Molecular Templates, Inc. Is one of the major oversold players in this sector.
Benzinga · 03/19 12:08
Weekly Report: what happened at PACB last week (0311-0315)?
Weekly Report · 03/18 09:29
PacBio's (PACB) New Panel to Aid Its Clinical Research Solution
NASDAQ · 03/13 14:17
Pacific Biosciences of California Becomes Oversold (PACB)
NASDAQ · 03/12 20:21
How Is The Market Feeling About Pacific Biosciences?
Pacific Biosciences's short percent of float has risen 18.14% since its last report. The company has 40.38 million shares sold short. Short interest is the number of shares that have been sold short but have not yet been covered. Short selling is when a trader sells shares of a company in the hope the price will fall.
Benzinga · 03/12 19:30
Weekly Report: what happened at PACB last week (0304-0308)?
Weekly Report · 03/11 09:28
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its weakness. Pacific Biosciences of California, Inc. Has an RSI near or below 30. The company's stock fell 27% over the past five days.
Benzinga · 03/07 12:18
Weekly Report: what happened at PACB last week (0226-0301)?
Weekly Report · 03/04 09:29
Illumina's Turnaround Play: Betting On NovaSeq X Amidst Rising Competitive Tides
Illumina operates in the genetic and genomic analysis sector. The company's strategic priorities include achieving top-line growth, improving operation efficiency and divesting GRAIL. Illumina's NovaSeq X platform has been successful, but the door is open to competition.
Seeking Alpha · 02/29 00:08
Weekly Report: what happened at PACB last week (0219-0223)?
Weekly Report · 02/26 09:32
Have Insiders Sold Pacific Biosciences of California Shares Recently?
Pacific Biosciences of California, Inc. President Christian O. Henry recently sold US$481k worth of stock at US$5.94 per share. The sale of 22% of a company's shares is a bad sign for shareholders. In the last year, Pacific Bioscience of California insiders didn't buy any shares. The company has a low insider ownership of 0.3% of the company.
Simply Wall St · 02/25 12:15
U.S. RESEARCH ROUNDUP-Home Depot, Palo Alto Networks, Wendys
Wall Street analysts revise their ratings and price targets on several U.S.-listed companies. Home Depot, Palo Alto Networks, Wendys and Wendys among companies with revised targets. Discover Financial Services, Cardinal Health and other companies see analyst downgrades. Some analysts raised their target prices for the companies.
Reuters · 02/21 06:59
Tuesday's ETF Movers: IDLV, ARKK
NASDAQ · 02/20 17:12
Pacific Biosciences of California is Now Oversold (PACB)
NASDAQ · 02/20 16:59
Pacific Biosciences (PACB) Gets a Buy from Scotiabank
TipRanks · 02/20 12:27
12 Health Care Stocks Moving In Monday's Intraday Session
Applied Therapeutics stock rose 42.5% to $5.34 during Monday's regular session. Universe Pharmaceuticals (NASDAQ:UPC) shares moved upwards by 41.86%. AMN Healthcare Services (NYSE:AMN) stock declined by 20.7% during the session.
Benzinga · 02/19 17:30
Weekly Report: what happened at PACB last week (0212-0216)?
Weekly Report · 02/19 09:32
More
Webull provides a variety of real-time PACB stock news. You can receive the latest news about Pacific Biosc through multiple platforms. This information may help you make smarter investment decisions.
About PACB
Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding (SBB) short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which accurately detects the nucleotide sequence and epigenetic status of individual DNA molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.